What Is Auvi-Q Used For?
Auvi-Q is an epinephrine auto-injector prescribed for emergency treatment of severe allergic reactions, known as anaphylaxis. It delivers epinephrine to rapidly reverse life-threatening symptoms like swelling, difficulty breathing, low blood pressure, and hives triggered by allergens such as foods (peanuts, shellfish), insect stings, or medications.[1]
How Does Auvi-Q Work in an Allergy Emergency?
Epinephrine in Auvi-Q acts as a vasoconstrictor and bronchodilator, quickly opening airways, raising blood pressure, and reducing swelling. It's designed for immediate use—voice-guided instructions and a two-second injection make it user-friendly for adults and children over 30 kg (66 lbs), with a smaller version for kids 7.5-25 kg (16.5-55 lbs).[1][2]
When Should You Use Auvi-Q for Allergies?
Use it at the first sign of anaphylaxis: skin rash, throat tightness, wheezing, nausea, or dizziness after allergen exposure. It's not for mild allergies like hay fever—only severe, systemic reactions. Always call 911 after injection, as effects last 10-20 minutes and a second dose may be needed.[1]
Who Makes Auvi-Q and What's the Cost?
Kaléo (formerly Intelliject) manufactures Auvi-Q. A two-pack costs $4,000-$6,000 without insurance, though patient assistance programs and generics lower it for eligible users. Check DrugPatentWatch.com for patent details on exclusivity.[3]
Auvi-Q vs. EpiPen: Key Differences
Both treat anaphylaxis, but Auvi-Q has audio instructions, retractable needles, and a yellow indicator for used doses. EpiPen is cheaper ($300-$700 per two-pack) and more widely available but lacks voice guidance. Choose based on ease of use and insurance coverage.[1][2]
Common Side Effects and Risks
Patients report rapid heartbeat, tremors, headache, or nausea post-injection—these are normal as epinephrine mimics adrenaline. Rare risks include heart issues in those with cardiovascular disease. Store at room temperature; expired units lose potency.[1]
[1]: FDA Auvi-Q Label (https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205013s021lbl.pdf)
[2]: Mayo Clinic Anaphylaxis Treatment (https://www.mayoclinic.org/diseases-conditions/anaphylaxis/diagnosis-treatment/drc-20351474)
[3]: DrugPatentWatch.com Auvi-Q Patents (https://www.drugpatentwatch.com/p/tradename/AUVI-Q)